Page: Nitrosamine impurities in specific medicines-2025/2/28

Page: Procedures for monograph and list entry establishment-2025/2/28

Document: List of centrally authorised products with safety-related changes to the product information-2025/2/28

Document: Procedural advice on CHMP/CAT/PRAC Rapporteur/Co-Rapporteur appointment principles, objective criteria and methodology in accordance with Article 62 (1) of Regulation (EC) No 726/2004-2025/2/28

Document: Draft guideline on the clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome - Revision 2-2025/2/28

Page: Clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome - Scientific guideline-2025/2/28

Document: Minutes of the CAT meeting 22-24 January 2025-2025/2/27

Document: Infographic - Orphan Medicines in the EU-2025/2/27

Document: Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations-2025/2/27

Document: Clinical Trial Information System (CTIS) evaluation timelines-2025/2/27